Ono Pharmaceutical faces grilling by Full Court in patent extension appeal

Appeals 2021-11-04 9:20 pm By Miklos Bolza | Sydney

Please login to bookmark

Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au